Neogen Chemicals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	8,182	7,776	6,907	6,862	4,873	3,364
Revenue Growth (YoY)	5.66%	12.58%	0.65%	40.83%	44.84%	9.89%
Cost of Revenue	4,430	4,289	3,876	3,940	2,750	1,976
Gross Profit	3,752	3,486	3,031	2,922	2,123	1,388
Selling, General & Admin	919.4	685.9	659.9	499.6	334.1	208.6
Other Operating Expenses	1,537	1,439	1,272	1,307	924.4	537.2
Operating Expenses	2,721	2,401	2,159	1,967	1,374	813.2
Operating Income	1,031	1,085	871.8	954.2	749	574.6
Interest Expense	-555.1	-378.6	-377.8	-237	-178	-129.3
Interest & Investment Income	15.7	15.7	74.1	38.3	6	1.2
Earnings From Equity Investments	3	2	1.8	1	1.8	3.8
Other Non Operating Income (Expenses)	-64.7	-82	-42.2	-46.2	-12	-8.2
EBT Excluding Unusual Items	429.6	642.4	527.7	710.3	566.8	442.1
Gain (Loss) on Sale of Investments	-	-	-	-	3.9	-
Other Unusual Items	-140.8	-140.8	-	-	-	-
Pretax Income	288.8	501.6	527.7	710.3	570.7	442.1
Income Tax Expense	91.4	153.3	171.2	210.6	124.4	128.8
Net Income	197.4	348.3	356.5	499.7	446.3	313.3
Net Income to Common	197.4	348.3	356.5	499.7	446.3	313.3
Net Income Growth	-60.00%	-2.30%	-28.66%	11.96%	42.45%	9.33%
Shares Outstanding (Basic)	26	26	26	25	25	23
Shares Outstanding (Diluted)	26	26	26	25	25	23
Shares Change (YoY)	0.01%	3.29%	2.41%	-	6.88%	-0.00%
EPS (Basic)	7.48	13.20	13.96	20.04	17.90	13.43
EPS (Diluted)	7.48	13.20	13.96	20.03	17.90	13.43
EPS Growth	-60.02%	-5.43%	-30.31%	11.93%	33.28%	9.34%
Free Cash Flow	-	-1,217	-3,319	-1,328	-1,689	-514.5
Free Cash Flow Per Share	-	-46.13	-129.96	-53.27	-67.71	-22.05
Dividend Per Share	-	1.000	2.000	3.000	2.750	2.250
Dividend Growth	-	-50.00%	-33.33%	9.09%	22.22%	12.50%
Gross Margin	45.85%	44.84%	43.88%	42.58%	43.57%	41.25%
Operating Margin	12.60%	13.96%	12.62%	13.91%	15.37%	17.08%
Profit Margin	2.41%	4.48%	5.16%	7.28%	9.16%	9.31%
Free Cash Flow Margin	-	-15.65%	-48.06%	-19.36%	-34.66%	-15.29%
EBITDA	1,258	1,293	1,054	1,094	848.6	626.3
EBITDA Margin	15.38%	16.63%	15.26%	15.95%	17.42%	18.62%
D&A For EBITDA	227.75	208.1	181.9	140.1	99.6	51.7
EBIT	1,031	1,085	871.8	954.2	749	574.6
EBIT Margin	12.60%	13.96%	12.62%	13.91%	15.37%	17.08%
Effective Tax Rate	31.65%	30.56%	32.44%	29.65%	21.80%	29.13%
Revenue as Reported	8,240	7,816	6,981	6,906	4,883	3,366

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.